American Regent, Inc. Issues Voluntary Nationwide Recall of One Lot of Papaverine Hydrochloride Injection, USP 60 mg/ 2 mL Due to the Presence of Visible Particulate Matter

Recall Type: Drug Recall

Source: FDA Recall Notice

Recall Date: July 24, 2026

Summary: July 24, 2026 – Shirley, NY, American Regent, Inc. is conducting a nationwide voluntary recall of a single lot of Papaverine Hydrochloride Injection, USP, 60 mg/2 mL single dose vial to the consumer level. The product is being recalled due to the presence of particulate matter identified as glass an

Read the original recall notice

Medication Ingredient Resources

Need to check medication ingredients or possible allergen concerns? Visit PillParser.com for ingredient lookup and RxAllergyScan.com to compare medications against an allergen profile.

← Back to Recalls